March 2017 - Volume 28 - Issue 3
pp: 243-355
Subscribe to eTOC

Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A

Akbari, Bahman; Farajnia, Safar; Zarghami, Nosratollah; More

Anti-Cancer Drugs . 28(3):263-270, March 2017.

5-Fluorouracil degradation rate could predict toxicity in stages II–III colorectal cancer patients undergoing adjuvant FOLFOX

Onesti, Concetta E.; Botticelli, Andrea; La Torre, Marco; More

Anti-Cancer Drugs . 28(3):322-326, March 2017.

Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

Aspeslagh, Sandrine; Stein, Mark; Bahleda, Rastilav; More

Anti-Cancer Drugs . 28(3):341-349, March 2017.